OTC Markets EXMKT - Delayed Quote USD

Nutranomics, Inc. (NNRX)

0.0001
0.0000
(0.00%)
At close: May 14 at 4:00:00 PM EDT
Loading Chart for NNRX
  • Previous Close 0.0000
  • Open 0.0000
  • Bid --
  • Ask --
  • Day's Range 0.0000 - 0.0000
  • 52 Week Range 0.0000 - 0.0001
  • Volume 23,000
  • Avg. Volume 0
  • Market Cap (intraday) 1.632M
  • Beta (5Y Monthly) 1.40
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0100
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Nutranomics, Inc. engages in the research, development, and sale of nutritional food products. It offers approximately 480 nutritional supplements, including formulating vitamin, mineral, herbal, and probiotic supplements. The company provides Nutritional Blood Analysis, a tool to examine the customer's blood cells on a video monitor, live, in real time; and the patented Assimilation Enhancing System that improves the absorption of nutrients. In addition, it offers educational services, including various types of analyses, trainings, certifications, and group presentations to individuals and industry professionals. The company distributes its products through sales representatives throughout North America and Asia, as well as through retail stores. Nutranomics, Inc. has a strategic partnership with Terra-Formance, LLC. The company was founded in 1995 and is headquartered in Salt Lake City, Utah.

www.nutranomics.com

1

Full Time Employees

July 31

Fiscal Year Ends

Recent News: NNRX

View More

Performance Overview: NNRX

Trailing total returns as of 5/14/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

NNRX
0.00%
S&P 500 (^GSPC)
0.19%

1-Year Return

NNRX
100.00%
S&P 500 (^GSPC)
12.31%

3-Year Return

NNRX
66.67%
S&P 500 (^GSPC)
46.44%

5-Year Return

NNRX
0.00%
S&P 500 (^GSPC)
106.58%

Compare To: NNRX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: NNRX

View More

Valuation Measures

Annual
As of 1/3/2025
  • Market Cap

    1.63M

  • Enterprise Value

    1.63M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    25.93k

  • Diluted EPS (ttm)

    -0.0100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    34

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: NNRX

View More

Company Insights: NNRX

Research Reports: NNRX

View More

People Also Watch